Letter: Treatment of malignant haemopathies and urate oxidase.
作者信息
Kissel P, Mauuary G, Royer R, Toussain P
出版信息
Lancet. 1975 Jan 25;1(7900):229. doi: 10.1016/s0140-6736(75)91410-5.
PMID:47468
Abstract
摘要
相似文献
1
Letter: Treatment of malignant haemopathies and urate oxidase.
Lancet. 1975 Jan 25;1(7900):229. doi: 10.1016/s0140-6736(75)91410-5.
2
[Letter: Hyperuricemia in hematological pathology. Therapy and prevention using urate oxidase].
Nouv Presse Med. 1974 Sep 28;3(32):2026.
3
[Urate-oxidase: a new therapy of cytotoxic-drug-induced hyperuricemia (author's transl)].
Haematologica. 1981 Oct;66(5):656-66.
4
[Letter: Use of urate oxidase and allopurinol as hypouricemic agents in hematology].
Nouv Presse Med. 1976 Jan 10;5(2):91.
5
[Treatment of hyperuricemias in hematology using urate oxidase and allopurinol].[使用尿酸氧化酶和别嘌呤醇治疗血液学中的高尿酸血症]
Ann Med Interne (Paris). 1976 Jun-Jul;127(6-7):479-82.
6
[Letter: Prevention of hyperuricemic complications caused by treatment of acute leukemia].[信件：急性白血病治疗所致高尿酸血症并发症的预防]
Nouv Presse Med. 1976 Jan 17;5(3):146.
7
Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia.
J Pediatr. 1982 Jan;100(1):152-5. doi: 10.1016/s0022-3476(82)80259-x.
8
Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.尿酸氧化酶在预防和治疗与淋巴系统恶性肿瘤相关的高尿酸血症中的应用
Leukemia. 1997 Nov;11(11):1813-6. doi: 10.1038/sj.leu.2400850.
9
Hypouricaemic effect of polyethyleneglycol modified urate oxidase.
Lancet. 1981 Aug 8;2(8241):281-3. doi: 10.1016/s0140-6736(81)90528-6.
10
Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.尿酸氧化酶用于预防和治疗患癌儿童的肿瘤溶解综合征。
Cochrane Database Syst Rev. 2014 Aug 14(8):CD006945. doi: 10.1002/14651858.CD006945.pub3.
引用本文的文献
1
Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase.大聚合尿酸酶和 PEG 二醇对聚乙二醇化犬尿酸酶加速血液清除的影响。
PLoS One. 2012;7(6):e39659. doi: 10.1371/journal.pone.0039659. Epub 2012 Jun 26.
Zotero 插件